Trasylol Causes Complications During Heart Surgery

Trasylol is a medication that was approved by the FDA in 1999 to help control blood loss in patients undergoing open heart surgery. Studies have shown that Trasylol increases the risk of kidney failure, stroke, heart attack or heart failure. On November 5, 2007, at the request of the FDA, Bayer suspended global marketing of Trasylol.

Many patients who were given Trasylol during open heart surgery are unaware that they received the drug. Thus, medical records need to be reviewed to see if it was administered.

Did You Suffer Serious Side Effects? Contact Us Today.

If you or a loved one has been administered Trasylol and has undergone open heart surgery and suffered from kidney failure, stroke, heart attack or heart failure, you may be entitled to compensation for your injuries.

Our attorneys are here to help you obtain compensation for your injuries due to Trasylol use. Please contact us today for a free evaluation by calling James F. Humphreys & Associates, L.C., at 304-881-0652 or by completing our online form.